Renal haemodynamic and tubular actions of urotensin II in the rat

Journal of Endocrinology

Volumn 198, Issue 3, 2008, Pages 617-624

  Abdel Razik, Alaa E S ^a   Forty, Ellen J ^a   Balment, Richard J ^a   Ashton, Nick ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UROTENSIN II;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIURESIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; DRUG URINE LEVEL; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY TUBULE ABSORPTION; MALE; NATRIURESIS; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM URINE LEVEL; SPRAGUE DAWLEY RAT;

ANIMALS; BLOTTING, WESTERN; DIURESIS; GLOMERULAR FILTRATION RATE; HEMODYNAMICS; KIDNEY; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY TUBULES; MALE; NATRIURESIS; PEPTIDE HORMONES; POLYMERASE CHAIN REACTION; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RENAL CIRCULATION; RENIN; SODIUM; SPECTROPHOTOMETRY, ATOMIC; UROTENSINS;

EID: 53349145908     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0260     Document Type: Article

References (36)

1. Ames RS, Sarau HM, Chambers JK, Willette RN, Alyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW et al. 1999 Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401 282-286.
2. Ashton N 2006 Renal and vascular actions of urotensin II. Kidney International 70 624-629.
3. Balment RJ, Song W & Ashton N 2005 Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation. Annals of the New York Academy of Sciences 1040 66-73.
4. Bern HA, Pearson D, Larson BA & Nishioka RS 1985 Neurohormones from fish tails: the caudal neurosecretory system. I. 'Urophysiology' and the caudal neurosecretory system offishes. Recent Progress in Hormone Research 41 533-552.
5. Bond H, Winter Mj, Warne JM, McCrohan CR & Balment RJ 2002 Plasma concentrations of arginine vasotocin and urotensin II are reduced following transfer of the euryhaline flounder (Platichthys flesus) from seawater to fresh water. General and Comparative Endocrinology 125 113-120.
6. Boucard AA, Sauve SS, Guillemette G, Escher E & Leduc R 2003 Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. Biochemical Journal 370 829-838.
7. Bousette N, Pottinger J, Ramli W, Ohlstein EH, Dhanak D, Douglas SA & Giaid A 2006 Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease. Peptides 27 2919-2926.
8. Casarini DE, Boim MA, Stella RC, Krieger-Azzolini MH, Krieger JE & Schor N 1997 Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. American Journal of Physiology 272 F405-F409.
9. Charles CJ, Rademaker MT, Richards AM & Yandle TG 2005 Urotensin II: evidence for cardiac, hepatic and renal production. Peptides 26 2211-2214.
10. Cheung BM, Leung R, Man YB & Wong LY 2004 Plasma concentration of urotensin II is raised in hypertension. Journal of Hypertension 22 1341-1344.
11. Disa J, Floyd LE, Edwards RM, Douglas SA & Aiyar NV 2006 Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography. Peptides 27 1532-1537.
12. Douglas SA & Ohlstein EH 2000 Urotensin receptors. In The IUPHAR Compendium of Receptor Characterization and Classification, pp 365-372. Ed. D Girdlestone. London: IUPHAR Media.
13. Douglas SA, Dhanak D & Johns DG 2004 From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function. Trends in Pharmacological Sciences 25 76-85.
14. Dworkin LD & Brenner BM 1996 The renal circulations. In The Kidney, 5, pp 247-285. Ed. BM Brenner. Philadelphia: WB. Saunders.
15. Elshourbagy NA, Douglas SA, Shabon U, Harrison S, Duddy G, Sechler JL, Ao Z, Maleeff BE, Naselsky D, Disa J et al. 2002 Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. British Journal of Pharmacology 136 9-22.
16. Gardiner SM, March JE, Kemp PA, Davenport AP & Bennett T 2001 Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. British Journal of Pharmacology 132 1625-1629.
17. Gardiner SM, March JE, Kemp PA, Maguire JJ, Kuc RE, Davenport AP & Bennett T 2006 Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation. British Journal of Pharmacology 147 612-621.
18. Ito S & Abe K 1997 Contractile properties of afferent and efferent arterioles. Clinical and Experimental Pharmacology and Physiology 24 532-535.
19. Labarrere P, Chatenet D, Leprince J, Marionneau C, Loirand G, Tonon MC, Dubessy C, Scalbert E, Pfeiffer B, Renard P et al. 2003 Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. Journal of Enzyme Inhibition and Medicinal Chemistry 18 77-88.
20. Lamarre NS & Tallarida RJ 2008 A quantitative study to assess synergistic interactions between urotensin II and angiotensin II. European Journal of Pharmacology 586 350-351.
21. Loretz CA 1985 Species specificity and cellular mechanism of action of urotensin II in osmoregulation. In Neurosecretion and the Biology of Neuropeptides, pp 479-485. Eds H Kobayashi, HA Bern & A Urano. Berlin: Springer-Verlag.
22. Loretz CA, Bern HA, Foskett JK & Mainoya JR 1981 The caudal neurosecretory system and osmoregulation in fish. In Neurosecretion: Molecules, Cells, Systems, pp 319-328. Eds DS Farner & K Lederis. New York: Plenum Press.
23. Marshall WS & Bern HA 1979 Teleostean urophysis: urotensin II and ion transport across the isolated skin of a marine teleost. Science 204 519-521.
24. Marshall WS & Bern HA 1981 Active chloride transport by the skin of a marine teleost is stimulated by urotensin I and inhibited by urotensin II. General and Comparative Endocrinology 43 484-491.
25. Matsushita M, Shichiri M, Imai T, Iwashina M, Tanaka H, Takasu N & Hirata Y 2001 Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. Journal of Hypertension 19 2185-2190.
26. Matsushita M, Shichiri M, Fukai N, Ozawa N, Yoshimoto T, Takasu N & Hirata Y 2003 Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 144 1825-1831.
27. Nothacker HP, Wang Z, McNeill AM, Saito Y, Merten S, O'Dowd B, Duckles SP & Civelli O 1999 Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nature Cell Biology 1 383-385.
28. Ovcharenko E, Abassi Z, Rubinstein I, Kaballa A, Hoffman A & Winaver J 2006 Renal effects of human urotensin-II in rats with experimental congestive heart failure. Nephrology, Dialysis, Transplantation 21 1205-1211.
29. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K et al. 1999 Elements of a paracrine tubular renin angiotensin system along the entire nephron. Hypertension 34 1265-1274.
30. Russell FD, Meyers D, Galbraith AJ, Bett N, Toth I, Kearns P & Molenaar P 2003 Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. American Journal of Physiology. Heart and Circulatory Physiology 285 H1576-H1581.
31. Sahajpal V & Ashton N 2005 Increased glomerular angiotensin II binding in rats exposed to a maternal low protein diet in utero. Journal of Physiology 563 193-201.
32. Song W, Abdel-Razik AE, Lu W, Ao Z, Johns DG, Douglas SA, Balment RJ & Ashton N 2006 Urotensin II and renal function in the rat. Kidney International 69 1360-1368.
33. Totsune K, Takahashi K, Arihara Z, Sone M, Satoh F, Ito S, Kimura Y, Sasano H & Murakami O 2001 Role of urotensin II in patients on dialysis. Lancet 358 810-811.
34. Totsune K, Takahashi K, Arihara Z, Sone M, Murakami O, Ito S, Kikuya M, Ohkubo T, Hashimoto J & Imai Y 2004 Elevated plasma levels of immunoreactive urotensin II and its increased urinary excretion in patients with Type 2 diabetes mellitus: association with progress of diabetic nephropathy. Peptides 25 1809-1814.
35. Wang YX, Ding YJ, Zhu YZ, Shi Y, Yao T & Zhu YC 2007 Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction. American Journal of Physiology. Heart and Circulatory Physiology 292 H348-H359.
36. Zhang AY, Chen YF, Zhang DX, Yi FX, Qi J, Andrade-Gordon P, de Garavilla L, Li PL & Zou AP 2003 Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. American Journal of Physiology. Renal Physiology 285 F792-F798.